Matthew Tan

1.3k total citations · 1 hit paper
10 papers, 1.1k citations indexed

About

Matthew Tan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Matthew Tan has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Matthew Tan's work include Intraperitoneal and Appendiceal Malignancies (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). Matthew Tan is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). Matthew Tan collaborates with scholars based in United States, Sweden and Canada. Matthew Tan's co-authors include Susan Groshen, Cynthia G. Leichman, Joaquina Baranda, Lawrence Leichman, Ralf Metzger, William D. Boswell, P. V. Danenberg, Heinz-Josef Lenz, Kathleen D. Danenberg and Alexander Burnett and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Molecules.

In The Last Decade

Matthew Tan

10 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1997 513 citations Franco M. Muggia, John D. Hainsworth et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Matthew Tan

Since Specialization

Citations

This map shows the geographic impact of Matthew Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Tan more than expected).

Fields of papers citing papers by Matthew Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Tan. The network helps show where Matthew Tan may publish in the future.

Co-authorship network of co-authors of Matthew Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Tan. A scholar is included among the top collaborators of Matthew Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Tan. Matthew Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Challenges and Opportunities With Oncology Drug Development in China 2018 ·Clinical Pharmacology & Therapeutics ·Gaurav Bajaj, Manish Gupta, (unknown), Jeffrey S. Barrett, Matthew Tan, Katrin Rupalla, Richard Bertz, Jennifer Sheng	23
2	Identification of a Benzamide Derivative that Inhibits Stress-Induced Adrenal Corticosteroid Synthesis 2009 ·Molecules ·Jing Xu, Laurent Lecanu, Matthew Tan, (unknown), Vassilios Papadopoulos	1
3	The Benzamide Derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-piperazin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10) Reduces HIV-1 Infectivity in Vitro by Modifying Actin Dynamics 2006 ·Antiviral chemistry & chemotherapy ·Jing Xu, Laurent Lecanu, Matthew Tan, (unknown), (unknown), Vassilios Papadopoulos	3
4	Cryosurgical ablation of soft tissue sarcomas 1999 ·Cancer ·Lawrence R. Menendez, Matthew Tan, Milton Kiyabu, Sant P. Chawla	14
5	Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. 1997 ·Journal of Clinical Oncology ·Cynthia G. Leichman, Heinz-Josef Lenz, Lawrence Leichman, Kathleen D. Danenberg, Joaquina Baranda, Susan Groshen, William D. Boswell, Ralf Metzger, Matthew Tan, P. V. Danenberg	397
6	Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. breakdown → 1997 ·Journal of Clinical Oncology ·Franco M. Muggia, John D. Hainsworth, Susan Jeffers, Paul Miller, Susan Groshen, Matthew Tan, L Roman, Beatrice Uziely, Laila I. Muderspach, Agustin Garcia, Alexander Burnett, Filippo Greco, C. Paul Morrow, Linda J. Paradiso, (unknown)	513
7	Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy 1997 ·Cancer ·Peter F. Crookes, Cynthia G. Leichman, Lawrence Leichman, Matthew Tan, Loren Laine, Steven C. Stain, Joaquina Baranda, (unknown), Susan Groshen, Howard Silberman	87
8	Routine pre-contrast CT for liver lesion detection a re-examination 1997 ·Clinical Imaging ·(unknown), (unknown), Matthew Tan	1
9	Pegylated Liposomal Doxorubicin: Antitumor Activity in Epithelial Ovarian Cancer or Cancers of Peritoneal Origin 1997 ·Franco M. Muggia, Tamar Safra, Susan Groshen, Susan Jeffers, Lynda D. Roman, Matthew Tan, Laila I. Muderspach, Alexander Burnett, Silvia C. Formenti, C. Paul Morrow, Michael Amantea	6
10	Randomized sequential hormonal therapy vs adrenalectomy for metastatic breast carcinoma 1977 ·Cancer ·Robert H. Yonemoto, Matthew Tan, Ralph L. Byron, Daniel U. Riihimaki, (unknown), (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact